Vizgen championing the power of spatial genomics with unprecedented transformative insight into biological systems

Closely-held Vizgen is pioneering next-generation genomics and benchmarking the spatial genomics field with its commercial MERSCOPE Platform, the industry’s first high plex in situ single-cell spatial genomics solution, an essential tool for advancing human health through drug discovery and development.

“With the MERSCOPE Platform, researchers are able to visualize biological systems that govern human health and disease for the very first time in their natural spatial location – enabling new insights into a wide range of tissue-scale basic research and translational medicine in oncology, immunology, neuroscience, cell and gene therapy, infectious disease, and developmental biology,” Terry Lo, President and CEO of Vizgen says in an interview with BioTuesdays.